News

Simafex inspected by the FDA

05.06.2013 22:00

In February 2013, Simafex was inspected by the FDA

In February 2013, Simafex was inspected by the FDA regarding the synthesis of the Active Pharamaceutical Ingredient of DOTAREM which will be marketed in USA in the near future. The audit was successfully completed since no corrective action was requested (NAI : No Action Indicated)

See this article in the french newspaper Sud Ouest